A recent study in the journal Radiology tested whether 17 radiologists could identify when an X-ray was created using ...
A recent survey from The Physicians Foundation found that over half of doctors cite mis- and disinformation as hindering ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
An analysis of AI-powered devices that received FDA's "breakthrough" label shows a preference for big-picture, multi-problem ...
Prevention is normally relegated to the periphery of national conferences. Lacking the adrenaline of interventional ...
Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill ...
WASHINGTON — Food and Drug Administration Commissioner Marty Makary recounted his agency’s achievements and acknowledged a ...
The FDA has often failed to share information on how it determines whether advisory committee members have financial ...
Novo Nordisk said yesterday that it will start selling its obesity drugs at a lower cash price to patients if they enroll in ...
WASHINGTON — The Trump administration has prepared an order that would impose a 100% tariff on imports of patented ...
AI scribes saved doctors, across five academic medical centers, about 16 minutes per eight hours of patient care, a new study ...
A quiet effort to change the name of PCOS is nearing completion, driven in part by growing evidence of a male version.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results